Trials / Unknown
UnknownNCT05632744
Evaluation of CG-100 Intraluminal Bypass Device
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Colospan Ltd. · Industry
- Sex
- All
- Age
- 22 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of CG-100 Intraluminal Bypass device
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CG-100 Intraluminal Bypass Device | Subjects will be treated with the CG-100 Intraluminal Bypass Device |
Timeline
- Start date
- 2023-03-15
- Primary completion
- 2024-06-15
- Completion
- 2024-06-15
- First posted
- 2022-12-01
- Last updated
- 2024-02-14
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT05632744. Inclusion in this directory is not an endorsement.